Hormonal steroid contraceptives: a further review of adverse reactions.
作者信息
McQueen E G
出版信息
Drugs. 1978 Oct;16(4):322-57. doi: 10.2165/00003495-197816040-00003.
Abstract
摘要
相似文献
1
Hormonal steroid contraceptives: a further review of adverse reactions.激素甾体避孕药：不良反应的进一步综述。
Drugs. 1978 Oct;16(4):322-57. doi: 10.2165/00003495-197816040-00003.
2
[Metabolic repercussions of oral contraception (author's transl)].口服避孕药的代谢影响（作者译）
J Pharm Belg. 1978 Sep-Oct;33(5):312-24.
3
[The pill and thromboembolism. 1. Thrombogenesis and additional risk factors. A review of the literature].[避孕药与血栓栓塞。1. 血栓形成及其他风险因素。文献综述]
Ther Ggw. 1979 Oct;118(10):1550-74.
4
[Oral contraceptives: pharmacotherapy of normal women (author's transl)].口服避孕药：正常女性的药物治疗（作者译）
Schweiz Rundsch Med Prax. 1976 Jan 6;65(1):3-5.
5
Hormonal contraceptives. Past, present, and future.
Postgrad Med. 1984 Apr;75(5):75-7, 80, 83-6. doi: 10.1080/00325481.1984.11697991.
6
Hormonal steroid contraceptives. 3. Adverse reactions.激素甾体避孕药。3. 不良反应。
Drugs. 1971;2(1):20-44. doi: 10.2165/00003495-197102010-00003.
7
[Oral contraceptives: cardiovascular complications and additional risk factors (author's transl)].口服避孕药：心血管并发症及其他危险因素（作者译）
Schweiz Rundsch Med Prax. 1979 Oct 9;68(41):1321-9.
8
The pill revisited.
Fam Plann Perspect. 1975 Mar-Apr;7(2):62-71.
9
[Oral contraceptives and cardiovascular complications].
Arq Bras Cardiol. 1983 Mar;40(3):215-21.
10
The pill and circulatory disease.药丸与循环系统疾病。
Am Heart J. 1979 Feb;97(2):263-4. doi: 10.1016/0002-8703(79)90365-x.
引用本文的文献
1
Irreversible Binding of Norethisterone to Human Serum Protein Induced by UV-B Light.UV-B 光诱导去氧孕烯与人体血清蛋白的不可逆结合。
Pharm Res. 1984 May;1(3):126-9. doi: 10.1023/A:1016328120354.
2
The effect of oral contraceptives on mononuclear cell cholesteryl ester hydrolase activity.口服避孕药对单核细胞胆固醇酯水解酶活性的影响。
Lipids. 1980 Jan;15(1):39-44. doi: 10.1007/BF02534116.
3
Cholesteryl ester hydrolase activity in human symptomatic atherosclerosis.人类症状性动脉粥样硬化中的胆固醇酯水解酶活性
Lipids. 1980 Dec;15(12):1019-22. doi: 10.1007/BF02534317.
本文引用的文献
1
Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report.口服避孕药使用与血栓栓塞性疾病关系的调查。进一步报告。
Br Med J. 1969 Jun 14;2(5658):651-7. doi: 10.1136/bmj.2.5658.651.
2
Neuro-ophthalmic sequelae in users of oral contraceptives.口服避孕药使用者的神经眼科后遗症
JAMA. 1968 Sep 30;206(1):85-91.
3
Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs.血栓栓塞性疾病与口服避孕药的甾体成分。提交给药品安全委员会的一份报告。
Br Med J. 1970 Apr 25;2(5703):203-9. doi: 10.1136/bmj.2.5703.203.
4
Aorto-iliac occlusion in women using oral contraceptives. A report of 2 cases.
Br J Surg. 1971 Jul;58(7):508-9. doi: 10.1002/bjs.1800580709.
5
Decreased serum B 12 levels with oral contraceptive use.
JAMA. 1972 Sep 18;221(12):1371-4.
6
Hormonal steroid contraceptives. 3. Adverse reactions.激素甾体避孕药。3. 不良反应。
Drugs. 1971;2(1):20-44. doi: 10.2165/00003495-197102010-00003.
7
Oral contraceptives and hypertension. A report from the Boston Collaborative Drug Surveillance Program.
Obstet Gynecol. 1974 Sep;44(3):412-7.
8
Oral contraceptives and congenital limb-reduction defects.口服避孕药与先天性肢体减少缺陷
N Engl J Med. 1974 Oct 3;291(14):697-700. doi: 10.1056/NEJM197410032911403.
9
Haemodynamic effects of combined oestrogen-progestogen oral contraceptives.
J Obstet Gynaecol Br Commonw. 1974 Jul;81(7):517-25.
10
Peripheral haemodynamic effects of combined oestrogen-progestogen oral contraceptives.
J Obstet Gynaecol Br Commonw. 1974 Jul;81(7):526-34. doi: 10.1111/j.1471-0528.1974.tb00510.x.
Zotero 插件